Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
23 studies found for:    bavituximab
Show Display Options
Rank Status Study
1 Completed A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Bavituximab
2 Completed Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Interventions: Biological: bavituximab;   Drug: Gemcitabine
3 Terminated Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms
Intervention: Drug: Cabazitaxel plus bavituximab
4 Withdrawn A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer
Conditions: Breast Cancer;   Triple Negative Breast Neoplasms;   Triple-Negative Breast Neoplasm;   Triple-Negative Breast Cancer;   Triple Negative Breast Cancer;   ER-Negative PR-Negative HER2-Negative Breast Neoplasms;   ER-Negative PR-Negative HER2-Negative Breast Cancer
Interventions: Biological: Bavituximab;   Drug: Taxane
5 Suspended Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Biological: Bavituximab;   Drug: Taxane
6 Active, not recruiting Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Intervention: Drug: bavituximab and sorafenib
7 Completed Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
Condition: Non-Squamous Non-Small Cell Lung Cancer
Interventions: Drug: Paclitaxel / Carboplatin;   Drug: bavituximab
8 Completed Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: bavituximab plus paclitaxel and carboplatin
9 Completed Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infection
Condition: Hepatitis C
Interventions: Drug: Bavituximab;   Drug: Pegylated interferon (PEG-IFN)
10 Completed Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Condition: Non-small-cell Lung Cancer
Intervention: Drug: Docetaxel plus bavituximab or placebo
11 Not yet recruiting Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
Condition: Glioblastoma
Interventions: Drug: Temozolomide;   Drug: Bavituximab;   Radiation: Radiation
12 Completed Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies
Condition: Tumors
Intervention: Drug: Bavituximab
13 Completed Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer
Conditions: Non-Small-Cell Lung Cancer Stage IIIB;   Non-Small-Cell Lung Cancer Stage IV;   Non-Small-Cell Lung Cancer Metastatic;   Carcinoma, Non-Small-Cell Lung;   Non-Small Cell Lung Cancer;   Non-Small-Cell Lung Carcinoma;   Nonsmall Cell Lung Cancer
Interventions: Biological: bavituximab;   Drug: Docetaxel;   Other: Placebo (for bavituximab)
14 Active, not recruiting A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma
Condition: Rectal Adenocarcinoma
Interventions: Radiation: Radiation;   Drug: Bavituximab;   Drug: Capecitabine
15 Completed Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer
Condition: Carcinoma Breast Stage IV
Intervention: Drug: Bavituximab
16 Completed Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
Conditions: Hepatitis C Virus;   Hiv Infections
Intervention: Drug: bavituximab
17 Withdrawn Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Biological: durvalumab;   Biological: bavituximab
18 Active, not recruiting Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects
Condition: Non Small Cell Lung Cancer (NSCLC)
Intervention: Drug: Bavituximab
19 Completed Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
Conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: paclitaxel;   Biological: bavituximab;   Other: laboratory biomarker analysis;   Other: pharmacological study
20 Recruiting Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
Conditions: HepatoCellular Carcinoma;   Unresectable HepatoCellular Carcinoma;   Liver Cancer
Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT);   Drug: Sorafenib;   Drug: Bavituximab

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.